The purpose of this experimental study was to investigate the protective role of intratympanically administered dexamethasone on the inner ears of rats that were exposed to streptomycin ototoxicity. Twenty-four adult Wistar albino rats were separated into 4 groups: Group 1 (only streptomycin), Group 2 (only intratympanic dexamethasone), Group 3 (streptomycin and intratympanic dexamethasone), and Group 4 (streptomycin and intratympanic saline). All rats were evaluated with distortion product otoacoustic emissions (DPOAE) tests before the start of treatment and on the day it ended. On the 45th day, after the final DPOAE tests, animals of all groups were sacrificed under general anesthesia. The differences between the amplitudes of DPOAE results were determined, and hearing results were statistically analyzed. Also, the cochleas of each rat were histopathologically evaluated under a light microscope with hematoxylin and eosin staining. In the intratympanic dexamethasone group it was observed that cochlear hair cells were mostly protected. No significant difference was seen between the DPOAE results before and after treatment (p >0.05). On the other hand, loss was observed in the hearing functions and hair cells of the rats that received streptomycin and streptomycin plus intratympanic saline (p <0.05). In the streptomycin plus intratympanic dexamethasone group, the cochlear hair cells were partially protected. A significant difference was observed when the DPOAE results (DP-grams) of the streptomycin plus intratypmanic dexamethasone group were compared to those of the streptomycin plus intratympanic saline group (p <0.05). After the experimental study, ototoxic effects of the administration of streptomycin and intratympanic dexamethasone were observed on the rats' cochlear hair cells. We conclude that intratympanic dexamethasone has protective effects against this cochlear damage in rats.
Introduction
Streptomycin is an aminoglycoside antibiotic. Besides being the first drug in this class to be discovered, it was the first antibiotic used to treat tuberculosis. 1 After its widespread use in the treatment of tuberculosis, streptomycin drew attention because of its ototoxic effects. In the following years, its severe ototoxic effects led to limitations in its clinical use. 2 The rate of ototoxicity from aminoglycoside treatment has been reported to be between 2 and 25%. 3 It has been shown in studies that ototoxic damage due to aminoglycosides originates from the base of the cochlea and progresses toward the apex. 4 Therefore, the hearing loss initially occurs at higher frequencies and continues with the loss of lower frequencies. Damage also progresses from the outer hair cells to the inner hair cells of the basal membrane. Complete damage of the organ of Corti, partial damage of the stria vascularis, and damage to the VIIIth cranial nerve have been observed. 4 Clinically, ototoxicity manifests itself as hearing loss, ringing in the ears, and dizziness. 5 The effects of aminoglycosides are evaluated as vestibulotoxic and cochleotoxic. Streptomycin is the most vestibulotoxic aminoglycoside, and it also causes damage to hearing function. 6 Corticosteroids are used in inner ear diseases such as idiopathic sensorineural hearing loss, autoimmune hearing loss, and Ménière disease. In recent years especially, otolaryngologists have preferred intratympanic administration in these diseases because of the systemic side effects of corticosteroids. Methylprednisolone and dexamethasone are the most commonly used corticosteroids for intratympanic administration. 8, 9 In our study, we aimed to demonstrate the histopathologic changes and audiologic effects as measured by distortion product otoacoustic emissions (DPOAE) of intratympanically administered dexamethasone on the rat inner ear exposed to streptomycin ototoxicity.
Materials and methods
All experimental procedures were performed in accordance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals. 10 The study was also approved by the Ethical Committee at our institution under permit 10.10.2013/6.
Animals and drug administration. In our study, 24 healthy male Wistar albino rats weighing between 195 and 290 grams and having intact outer ear canals and tympanic membranes on otoscopic examination were used. The rats were housed in an environment with a standard temperature (22 ± 2°C) and light/dark cycle (12 hours daylight/12 hours darkness) in plastic cages with adequate food and water.
Streptomycin, 20 mg/kg, was administered intramuscularly daily in Groups 1, 3, and 4, and approximately 0.2 to 0.3 ml of dexamethasone (4 mg/ml) was administered intratympanically in Groups 2 and 3 on days 3, 10, 21, and 35. Saline (0.2 to 0.3 ml of physiologic salt water [0.9% NaCl]) was administered intratympanically to the rats in Group 4 on the same days. The rats were sacrificed 45 days after the first injection.
Experimental design. The rats were randomly separated into 4 groups with 6 rats (12 ears) in each group. In Group 1 (only streptomycin), streptomycin was administered every day. In Group 2 (only intratympanic dexamethasone), dexamethasone was delivered to the pars tensa of the tympanic membrane in the tympanic cavity under a surgical microscope on days 3, 10, 21, and 35. After 30 minutes, the same was done to the other ear at the same position.
In Group 3 (streptomycin and intratympanic dexamethasone), intratympanic dexamethasone was delivered to the tympanic cavity of the rats that also received streptomycin every day. Dexamethasone was administered according to the procedure described for Group 2.
In Group 4 (streptomycin and intratympanic saline), the procedure described for Group 3 was applied, with saline (0.9% NaCl) instead of dexamethasone being administered to the tympanic cavity.
Anesthesia. All rats were anesthetized with 60 mg/kg intraperitoneal ketamine and 10 mg/kg intramuscular 2% xylazine. DPOAE measurements. DPOAE tests were used to determine the intactness of the rats' hair cells. The tests were conducted in a silent room (less than 50 dB background noise) on all rats under anesthesia before and at the end of the study. The right and left ears of each rat were tested with the help of a standard commercial measurement device. The obtained data were processed and then evaluated with the EZ-Screen 2 software (Otodynamics Ltd.; Hatfield, UK). Each test took approximately 3 minutes.
After the animals were administered anesthesia, the primary tones were introduced into their outer ears through an inserted earphone using a plastic adapter that sealed the probe in the outer ear canal. Equilevel primary tones f1 (65 dB) and f2 (55 dB) were fixed at f1/f2 = 1.22, and DPOAEs were measured at 5 different frequencies ranging from 2,002 to 8,008 Hz (2,002, 3,003, 4,004, 6,006, and 8,008 Hz). The DPOAEs were provided as DP-grams.
The baseline hearing status of all animals was determined with a DP-gram, and the signal-to-noise ratio (SNR) was found. For each animal, SNRs at 5 frequencies were recorded. Data were collected separately for each rat, and the results were statistically analyzed.
Tissue preparation and histopathologic examination. All procedures were carried out in hygienic but nonsterile environments. On the 45th day, the rats were decapitated while under anesthesia. The temporal bones were fixed in a 10% formaldehyde solution for 1 week. After being rinsed in tap water for approximately 4 hours, they were decalcified in a 10% formic acid solution for 72 hours and then a 5% formic acid solution for 1 week.
After the decalcification procedure, each temporal bone was resected along the midline and dissected with a scalpel and scissors. After the outer ear canal was opened, the tympanic bulla in the temporal bone was manually located with the thumb. It was separated from the other structures to reveal the cochlea within it. The bulla was then opened, and hemostatic clamps were used to make an opening in the posterior air sinuses (mastoid).
Next, the bony parts were broken with a single movement along the outer ear canal, and the cochlea was revealed. The cochlea was dissected from surrounding tissue and removed en bloc. Macroscopic sampling was done to make evaluation possible. The samples were rinsed in tap water for 4 hours to cleanse them of the formic acid and were then dehydrated in an automatic tissue-tracking device in a graded alcohol series. They were then buried in paraffin, and a paraffin block was prepared for each sample.
Preparations were made with a microtome device by taking 5-µm wide cross-sections from each block on a glass slide. The preparations were deparaffinized with a vacuum furnace and then processed with xylene to remove leftover paraffin. They were then stained in an automated staining machine with hematoxylin and eosin (H&E). After being mounted with Entellan and covered with a cover glass, the preparations were evaluated nicroscopically.
Meanwhile, tissue sections to be used for immunohistochemical studies were put on positively charged glass slides, cleansed of paraffin, and rinsed after reaction with the alcohol. After incubation with 0.1% and 1% H2O, they were rinsed with phosphate-buffered saline (PBS) and dyed with avidin-biotin.
Next, the cross-sections were treated with 10% normal bovine serum. Then, caspase-3 rat polyclonal IgG primary antibody was diluted with 1:400 normal bovine serum and the obtained sections were treated with caspase-3 overnight. PBS was dripped on the negative control segments. The next day, the cross-sections were rinsed with PBS and were first incubated with secondary antibody (biotin bovine anti-rat), then horseradish peroxidase. After the rinsing with PBS, they were conducted with 3,3'-diaminobenzidine chromogen. The sections were then rinsed with distilled water and stained with hematoxylin. They were rinsed with distilled water until the blue stain disappeared and closed after reacting with alcohol and xylene. The sections were evaluated under a light microscope based on the intensity of caspase-3 immunoreaction.
Statistical analysis. Data analyses were performed with the Statistical Package for the Social Sciences for Windows v. 15.0 software (SPSS, Inc.; Chicago). Results were analyzed statistically by the Kruskal-Wallis test to determine differences in amplitudes of DPOAEs and corresponding noise floor differences and thresholds for each frequency. The histopathologic variations between the different treatment groups were compared using the Mann-Whitney U test. A p value of <0.05 was considered statistically significant.
Results
The results were evaluated in two parts: hearing results and histopathologic results.
Hearing results. In the DP-grams, the amplitudes of the emissions in all of the sessions were greater than the noise floor throughout the testing frequencies. The DPAOE measurements from before the start of the study, (i.e., the day before the rats started receiving drugs) were not significantly different across the groups (p >0.05).
In the DPOAE measurements taken on the 45th day at the end of the experiment, a significant decrease was observed in Groups 1, 3, and 4 between the frequencies of 2,002 and 8,008 Hz (p <0.05). This decrease was determined to be statistically significant, while no significant change was observed in Group 2 (p >0.05) (figure 1). Significant deterioration was noticed in the DP-grams of Groups 1 and 4. Moreover, a statistically significant Figure 1 . Graphs show DP-gram results before and after treatment in Group 1 (A), Group 2 (B), Group 3 (C), and Group 4 (D) . Histopathologic results. When all groups stained with H&E were evaluated under a light microscope, it was observed that the outer hair cells were mostly conserved in Group 2 and partially conserved in Group 3. However serious losses were observed in the cochlear hair cells of Groups 1 and 4 (figure 2). When caspase-3 immunoreactivity was investigated during immunohistochemical examination, no activity was seen in Groups 2 and 3. Cytoplasmic or nuclear caspase-3 immunoreactivity was seen in the hair cells, supporting cells, and basilar membrane in Groups 1 and 4 (figure 3 ).
Discussion
In recent years the use of aminoglycosides has been restricted because of their ototoxic properties, especially in industrialized countries. 11 They are being used in developed countries in cases of resistant tuberculosis as a lifesaving treatment. 12 On the other hand, aminoglycosides are the most commonly prescribed antibiotics in developing and undeveloped countries for regional and economic reasons. 2 Because infectious diseases show regional characteristics, aminoglycosides are often prescribed as first-line therapy for multidrug-resistant bacteria in many types of infections, especially tuberculosis.
Permanent damage has been shown to occur in the sensory cells and supporting cells in the cochlea in human and animal experiments of long-term aminoglycoside treatments. 2, 13 Schirmer et al found in their study that severe damage occurred in the sensory epithelia of the cochlea in rats treated with streptomycin; they reported not seeing hair cells or supporting cells in the basilar membrane. 14 The histopathologic results in our study showed severe degeneration in the cochlear hair cells and cochlear nerve fibers of Groups 1 and 4, in accordance with the literature.
It has been shown in studies on ototoxicity that the mechanism that causes damage in the hair cells is related to free-oxygen radicals. 2 Various free-radical types have been observed in the inner ear in animal studies, and it is believed that these radicals cause oxidative stress, initiating apoptosis. 15 Although many hypotheses have been suggested to explain the ototoxic effects of aminoglycosides, the details of the biochemical and molecular mechanisms that explain the destruction of cochlear and vestibular hair cells are not fully understood.
In a study conducted in 2009, it was reported that protective drugs may be administered at high concentration when applied intratympanically because the drug goes directly to the inner ear. 16 Also, the writers reported that steroids, when injected inside the middle ear, can usually reach the scala tympani-scala vestibuli in a matter of minutes through the round window membrane and the minimal oval window membrane. 16 Thus, intratympanic administration provides high concentrations of perilymph levels while preventing the side effects of systemic use. For these reasons, intratympanic administrations have been used safely in inner ear diseases, sudden sensorineural hearing loss, and Ménière disease. 17, 18 Corticosteroids, especially dexamethasone, are administered intratympanically.
It is known that glucocorticoids have several physiologic effects on cochlear tissues. 9 Cochlear immunosuppressive and antiinflammatory functions are the most common reasons for their use in otology. 19 Cochlear explants stimulated with tumor necrosis factor alpha and naive cochlear explants treated with dexamethasone yield a significant increase in the level of phosphorylated NF-κB protein and decreases in the ratio of proapoptotic to antiapoptotic genes (Bax/Bcl 2). 20, 21 In addition to their restorative effects on autoimmunity dysfunctions, it has been shown that corticosteroids have an effect on ion transport within the stria vascularis of mice. 22 A substantial number of spiral ligament cells have glucocorticoid receptors, and this also supports the potential role of potassium ions in hemostasis. It has been shown that glucocorticoids' mechanism of action on drug-induced cochlear ototoxicity 23 is also effective on cochlear damage caused by ischemia, 24 mechanical damage, 25 and noise. 26 The increased numbers of apoptotic cells in the rat cochleas of Groups 1 and 4 were demonstrated with caspase-3. It was observed that these histopathologic findings were in accordance with the DPOAE results in terms of hearing loss. Ototoxic agents affect hair cells before other cochlear components. Otoacoustic emission measurements are ideal for monitoring cochlear functions in drug-originating ototoxicities. Stimulated otoacoustic emissions, especially DPOAEs due to their frequency specificity, are more sensitive in assessing outer hair cells. 27 Yılmaz et al found in their study that the outer hair cell functions remained unaffected in transient otoacoustic emissions measurements after intratympanic dexamethasone injections. 28 The DPOAE results of Group 2 were found to be consistent with these results.
A method of treatment to decrease the ototoxic effects of streptomycin has not yet been defined. In the various experimental studies conducted, different antifree-radical agents have been used to prevent ototoxicity, such as salicylates, D-methionine, estrogen, dizocilpine, deferoxamine, vitamin E, caffeic acid phenethyl ester, and ebselen. [29] [30] [31] [32] We wanted to observe the ototoxic effects of streptomycin on the inner ear and to show the protective activity of intratympanic steroid treatment against this ototoxicity. This was our purpose in examining the DPOAE results and the ultrastructural morphology and histopathologic changes of the cochlea.
At the end of our study we observed the occurrence of ototoxicity when streptomycin and intratympanic dexamethasone were applied together, but this ototoxicity was limited by the dexamethasone. We did not observe ototoxic changes in the administration of intratympanic dexamethasone alone. However, further well-designed, placebo-controlled human studies are necessary to verify our results and to form an intratympanic dexamethasone protocol in streptomycin ototoxicity. 
